ATE536167T1 - Zusammensetzung zur förderung der kollagenproduktion - Google Patents

Zusammensetzung zur förderung der kollagenproduktion

Info

Publication number
ATE536167T1
ATE536167T1 AT04792515T AT04792515T ATE536167T1 AT E536167 T1 ATE536167 T1 AT E536167T1 AT 04792515 T AT04792515 T AT 04792515T AT 04792515 T AT04792515 T AT 04792515T AT E536167 T1 ATE536167 T1 AT E536167T1
Authority
AT
Austria
Prior art keywords
collagen production
promoting collagen
composition
nucleic acid
related substance
Prior art date
Application number
AT04792515T
Other languages
English (en)
Inventor
Shigeo Shinohara
Mitsuaki Kawamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE536167T1 publication Critical patent/ATE536167T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT04792515T 2003-10-08 2004-10-08 Zusammensetzung zur förderung der kollagenproduktion ATE536167T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003349156 2003-10-08
PCT/JP2004/015298 WO2005034902A1 (ja) 2003-10-08 2004-10-08 コラーゲン産生促進用組成物

Publications (1)

Publication Number Publication Date
ATE536167T1 true ATE536167T1 (de) 2011-12-15

Family

ID=34430996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04792515T ATE536167T1 (de) 2003-10-08 2004-10-08 Zusammensetzung zur förderung der kollagenproduktion

Country Status (12)

Country Link
US (1) US7557093B2 (de)
EP (1) EP1671618B1 (de)
JP (2) JP4614886B2 (de)
KR (1) KR20060132817A (de)
CN (1) CN100569213C (de)
AT (1) ATE536167T1 (de)
AU (1) AU2004279248B2 (de)
BR (1) BRPI0415229A (de)
CA (1) CA2541584C (de)
ES (1) ES2376062T3 (de)
TW (1) TW200514575A (de)
WO (1) WO2005034902A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006225271A (ja) * 2005-02-15 2006-08-31 Otsuka Pharmaceut Co Ltd シワの予防又は改善剤
US9597266B2 (en) 2007-08-06 2017-03-21 Otsuka Pharmaceutical Co., Ltd. Gel composition for external application containing an adenine compound
KR100903654B1 (ko) 2007-10-10 2009-06-18 (주)더페이스샵코리아 하고초 추출물과 아데노신을 함유하는 화장료 조성물
ES2959848T3 (es) 2008-06-09 2024-02-28 Otsuka Pharma Co Ltd Composición para uso externo
AU2011270096B2 (en) 2010-06-25 2014-06-12 Otsuka Pharmaceutical Co., Ltd. Agent for suppressing the formation of abnormal skin cells caused by exposure to light
CN103501757B (zh) 2011-02-01 2016-01-20 株式会社林原 皮肤外用剂
JP5062922B2 (ja) 2011-02-14 2012-10-31 株式会社J−オイルミルズ 皮膚コラーゲン産生促進剤
JP2013193985A (ja) * 2012-03-19 2013-09-30 Kao Corp 育毛剤
JP6332902B2 (ja) * 2012-10-29 2018-05-30 株式会社ピカソ美化学研究所 美容用組成物
JP2014141475A (ja) * 2012-12-27 2014-08-07 Daiichi Sankyo Co Ltd 新規美白剤
KR101507224B1 (ko) * 2013-05-29 2015-03-30 부산대학교 산학협력단 마늘 유래 우라실을 유효성분으로 함유하는 주름 개선용 조성물
CN105491991B (zh) * 2013-10-29 2019-07-19 玫琳凯有限公司 化妆品组合物
JP7374585B2 (ja) 2017-02-08 2023-11-07 オリエンタル酵母工業株式会社 皮膚色素沈着抑制剤
WO2019021988A1 (ja) 2017-07-24 2019-01-31 大塚製薬株式会社 外用組成物
KR102026365B1 (ko) * 2018-05-11 2019-11-04 주식회사 네이처인랩 우리딘 및 활성촉진 복합체를 포함하는 화장료 조성물
EP4414001A4 (de) 2021-10-07 2025-12-03 Yamasa Corp Hautpflegezusammensetzung und verwendung davon sowie hautpflegezusammensetzungs-quellmaterial
KR20240165441A (ko) 2022-03-30 2024-11-22 야마사 쇼유 가부시키가이샤 콜라겐 산생 촉진제, 화장료 조성물 또는 피부 외용제 및 경구 투여제

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4266855A (en) 1979-09-24 1981-05-12 Quantor Corporation Quick change lens system
ES507187A0 (es) * 1981-11-16 1983-01-01 Union Ind Y Agro Ganader S A U Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
ES526873A0 (es) * 1982-10-27 1985-04-16 Crinos Industria Farmaco Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados
EP0256472A3 (de) 1986-08-11 1988-09-07 Lion Corporation Kosmetische Mittel zur Anwendung auf der Haut
JPS63183535A (ja) 1986-09-18 1988-07-28 Lion Corp 皮膚外用剤
US5182269A (en) * 1987-09-23 1993-01-26 Crinos Industria Farmacobiologica Spa Composition for topical use having hair stimulating, anti-dandruff and anti-seborrhoic activity
JP3818674B2 (ja) * 1992-06-02 2006-09-06 三省製薬株式会社 皮膚外用剤
JPH07233037A (ja) * 1993-12-29 1995-09-05 Sansho Seiyaku Co Ltd 皮膚化粧料
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
JPH09295915A (ja) 1996-04-26 1997-11-18 Kikkoman Corp 皮膚化粧料
GB9701374D0 (en) 1997-01-23 1997-03-12 Univ Liverpool Purinergic agonists and antagonists
US6203805B1 (en) * 1998-11-10 2001-03-20 Color Access, Inc. Topical compositions containing whey proteins
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
JP2001278783A (ja) 2000-03-29 2001-10-10 Shiseido Co Ltd コラーゲン産生促進剤
JP3608078B2 (ja) 2000-05-11 2005-01-05 株式会社アルソア本社 コラーゲン産生促進剤、エストロゲン様作用剤、皮膚化粧料および美容食品
US6759033B2 (en) * 2000-06-22 2004-07-06 Access Business Group International Llc Method for slowing the decomposition of a cosmetic composition
US7820636B2 (en) * 2001-04-13 2010-10-26 Otsuka Pharmaceutical Co., Ltd. Sugar intake promoters
DE10132338A1 (de) 2001-07-04 2003-01-16 Basf Ag Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
CN100471502C (zh) * 2002-04-09 2009-03-25 大塚制药株式会社 细胞增殖用组合物

Also Published As

Publication number Publication date
JP4614886B2 (ja) 2011-01-19
TW200514575A (en) 2005-05-01
ES2376062T3 (es) 2012-03-08
HK1093891A1 (zh) 2007-03-16
EP1671618A4 (de) 2009-11-11
WO2005034902A1 (ja) 2005-04-21
BRPI0415229A (pt) 2006-12-05
CN1867316A (zh) 2006-11-22
TWI347846B (de) 2011-09-01
JPWO2005034902A1 (ja) 2006-12-21
JP2010215648A (ja) 2010-09-30
KR20060132817A (ko) 2006-12-22
US20070135374A1 (en) 2007-06-14
US7557093B2 (en) 2009-07-07
AU2004279248A1 (en) 2005-04-21
CN100569213C (zh) 2009-12-16
EP1671618B1 (de) 2011-12-07
AU2004279248B2 (en) 2011-05-12
CA2541584A1 (en) 2005-04-21
CA2541584C (en) 2013-02-26
EP1671618A1 (de) 2006-06-21

Similar Documents

Publication Publication Date Title
ATE536167T1 (de) Zusammensetzung zur förderung der kollagenproduktion
DE602004021585D1 (de) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
ATE376446T1 (de) Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
WO2007024899A3 (en) Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
EP1498101A4 (de) Zusammensetzung für zellproliferation
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
ATE333863T1 (de) Zusammensetzungen enthaltend ein ethanolaminderivat sowie organische metallsalze
DE50107916D1 (de) Dreidimensionales hautmodell
EP2298275A4 (de) Zusammensetzung zur topischen anwendung
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
DE60335018D1 (de) Mittel zur verhinderung von hautalterung
ITMI20051616A1 (it) Intermedio multistrato utile per la preparazione di pelle artificiale ad aspetto scamosciato e metodo di preparazione
NO20091517L (no) Emulsjon
WO2005000224A3 (en) Novel dermatological composition
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
ATE363888T1 (de) Verwendung von adenosin oder einem adenosinanalogen zur glättung von feinen linien
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
DE602004018569D1 (de) Verwendung eines kosmetischen Wirkstoffs mit Extrakten von Schizosaccharomyces zur Aufhellung der Haut
ATE519479T1 (de) Kosmetikum mit anti-alterungswirkung
WO2010030092A3 (ko) 녹용 성분을 함유한 발모촉진물 및 그의 제조방법
WO2005102363A3 (en) Methods of promoting cartilage healing or cartilage integration
FR2959665A1 (fr) Procede pour appliquer un element decoratif dore sur la peau